Zhang Zhang

3PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 02, 2026
PET/CT-Guided Neoadjuvant Tislelizumab plus Chemotherapy/Chemoradiotherapy for Resectable Esophageal Squamous Cell Carcinoma: RATIONALE-213 Final Analysis.

Yushang Yang, Xiaolong Yan, Hongjing Jiang

|Sep 11, 2025
Reply to: "NOTCH1: A Potential New Biomarker in the Era of Immunotherapy?" and "Caution in Interpreting NOTCH1 Mutation as a Predictive Biomarker of Tislelizumab Response in Esophageal Squamous Cell Carcinoma".

Zhihao Lu, Wenting Du, Xi Jiao

|Aug 10, 2022
Doubly robust estimation of optimal dynamic treatment regimes with multicategory treatments and survival outcomes.

Zhang Zhang, Danhui Yi, Yiwei Fan

Pageof 1

Frequent Collaborators

1 joint publications

Yiwei Fan

1 joint publications

Zhihao Lu

1 joint publications

Lin Shen

1 joint publications

Yushang Yang